View publication

↩ Back to all publications
Publication
PropertyValue
Working Groups Levin
SubprojectNone
Open AccessOpen Access Yes
Publication TypeJournal Article
Peer ReviewedYes
PMIDPubMed ID 35500536
DOIDOI 10.1016/j.ebiom.2022.104021
Publication Year2022
TitleSafety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trial.
JournalEBioMedicine
ESSN2352-3964
URL https://www.ncbi.nlm.nih.gov/pubmed/?term=35500536%5Buid%5D
Pages104021
Volume80
Journal AbbreviationEBioMedicine
AuthorsLevin J, Sing N, Melbourne S, Morgan A, Mariner C, Spillantini MG, Wegrzynowicz M, Dalley JW, Langer S, Ryazanov S, Leonov A, Griesinger C, Schmidt F, Weckbecker D, Prager K, Matthias T, Giese A
First AuthorLevin J
Last AuthorGiese A